Pro Share Advisors LLC Organon & Co. Transaction History

Pro Share Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $921,076 - $1.32 Million	55,520 Added 137.02%	96,039 $1.67 Million
Q2 2023 Aug 10, 2023	BUY	$19.27 - $24.63 $23,644 - $30,221	1,227 Added 3.12%	40,519 $843,000
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $273,897 - $410,206	-12,787 Reduced 24.55%	39,292 $924,000
Q4 2022 Feb 02, 2023	SELL	$23.31 - $28.61 $14,149 - $17,366	-607 Reduced 1.15%	52,079 $1.46 Million
Q3 2022 Nov 04, 2022	SELL	$23.4 - $34.25 $72,189 - $105,661	-3,085 Reduced 5.53%	52,686 $1.23 Million
Q2 2022 Aug 01, 2022	SELL	$31.66 - $38.9 $512,480 - $629,674	-16,187 Reduced 22.5%	55,771 $1.88 Million
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $154,746 - $200,027	-5,082 Reduced 6.6%	71,958 $2.51 Million
Q4 2021 Feb 08, 2022	BUY	$28.67 - $37.13 $632,202 - $818,753	22,051 Added 40.1%	77,040 $2.35 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $1.12 Million - $1.4 Million	-39,211 Reduced 41.63%	54,989 $1.8 Million
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $2.68 Million - $3.58 Million	94,200 New	94,200 $2.85 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.